Fungal Infections in Intestinal Transplantation

Anum Abbas; Allie Lewis; Diana Florescu

doi:10.1007/s12281-022-00437-x

Fungal Infections in Intestinal Transplantation

Anum Abbas, Allie Lewis, Diana Florescu

Research output: Contribution to journal › Review article › peer-review

Abstract

Purpose of Review: Invasive fungal infections (IFIs) remain a cause of morbidity and mortality among solid organ transplant recipients. This review focuses of summarizing key clinical and diagnostics findings of yeast, mold, and endemic fungal infections in intestinal transplant recipients and recent advances in therapies. Recent Findings: There is limited data on IFIs in intestinal transplant recipients and the majority of infections are due to Candida. Several novel antifungal agents are in development as well as nanotechnology to combat antifungal resistance and emerging pathogens. Summary: Limited data regarding IFIs in intestinal transplant exist and further multi-center collaborative studies are needed to describe scope of IFIs in intestinal transplant recipients to improve the outcomes of this disease.

Original language	English (US)
Pages (from-to)	197-205
Number of pages	9
Journal	Current Fungal Infection Reports
Volume	16
Issue number	4
DOIs	https://doi.org/10.1007/s12281-022-00437-x
State	Published - Dec 2022

Keywords

Aspergillus
Candidiasis
Endemic fungal infections
Intestinal transplant
Invasive fungal infection
Mucormycosis

ASJC Scopus subject areas

Infectious Diseases

Access to Document

10.1007/s12281-022-00437-x

Cite this

@article{c715060c3b064854bd217214c805ede7,

title = "Fungal Infections in Intestinal Transplantation",

abstract = "Purpose of Review: Invasive fungal infections (IFIs) remain a cause of morbidity and mortality among solid organ transplant recipients. This review focuses of summarizing key clinical and diagnostics findings of yeast, mold, and endemic fungal infections in intestinal transplant recipients and recent advances in therapies. Recent Findings: There is limited data on IFIs in intestinal transplant recipients and the majority of infections are due to Candida. Several novel antifungal agents are in development as well as nanotechnology to combat antifungal resistance and emerging pathogens. Summary: Limited data regarding IFIs in intestinal transplant exist and further multi-center collaborative studies are needed to describe scope of IFIs in intestinal transplant recipients to improve the outcomes of this disease.",

keywords = "Aspergillus, Candidiasis, Endemic fungal infections, Intestinal transplant, Invasive fungal infection, Mucormycosis",

author = "Anum Abbas and Allie Lewis and Diana Florescu",

note = "Publisher Copyright: {\textcopyright} 2022, The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.",

year = "2022",

month = dec,

doi = "10.1007/s12281-022-00437-x",

language = "English (US)",

volume = "16",

pages = "197--205",

journal = "Current Fungal Infection Reports",

issn = "1936-3761",

publisher = "Current Science, Inc.",

number = "4",

}

TY - JOUR

T1 - Fungal Infections in Intestinal Transplantation

AU - Abbas, Anum

AU - Lewis, Allie

AU - Florescu, Diana

PY - 2022/12

Y1 - 2022/12

N2 - Purpose of Review: Invasive fungal infections (IFIs) remain a cause of morbidity and mortality among solid organ transplant recipients. This review focuses of summarizing key clinical and diagnostics findings of yeast, mold, and endemic fungal infections in intestinal transplant recipients and recent advances in therapies. Recent Findings: There is limited data on IFIs in intestinal transplant recipients and the majority of infections are due to Candida. Several novel antifungal agents are in development as well as nanotechnology to combat antifungal resistance and emerging pathogens. Summary: Limited data regarding IFIs in intestinal transplant exist and further multi-center collaborative studies are needed to describe scope of IFIs in intestinal transplant recipients to improve the outcomes of this disease.

AB - Purpose of Review: Invasive fungal infections (IFIs) remain a cause of morbidity and mortality among solid organ transplant recipients. This review focuses of summarizing key clinical and diagnostics findings of yeast, mold, and endemic fungal infections in intestinal transplant recipients and recent advances in therapies. Recent Findings: There is limited data on IFIs in intestinal transplant recipients and the majority of infections are due to Candida. Several novel antifungal agents are in development as well as nanotechnology to combat antifungal resistance and emerging pathogens. Summary: Limited data regarding IFIs in intestinal transplant exist and further multi-center collaborative studies are needed to describe scope of IFIs in intestinal transplant recipients to improve the outcomes of this disease.

KW - Aspergillus

KW - Candidiasis

KW - Endemic fungal infections

KW - Intestinal transplant

KW - Invasive fungal infection

KW - Mucormycosis

UR - http://www.scopus.com/inward/record.url?scp=85136155229&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85136155229&partnerID=8YFLogxK

U2 - 10.1007/s12281-022-00437-x

DO - 10.1007/s12281-022-00437-x

M3 - Review article

AN - SCOPUS:85136155229

VL - 16

SP - 197

EP - 205

JO - Current Fungal Infection Reports

JF - Current Fungal Infection Reports

SN - 1936-3761

IS - 4

ER -

Fungal Infections in Intestinal Transplantation

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this